Analysts See $1.26 EPS for Charles River Laboratories International, Inc. (CRL); Clearbridge Has Cut Its Lowes Cos (LOW) Position

January 14, 2018 - By Clifton Ray

Clearbridge Llc decreased Lowes Cos Inc (LOW) stake by 4.29% reported in 2017Q3 SEC filing. Clearbridge Llc sold 36,920 shares as Lowes Cos Inc (LOW)’s stock rose 10.23%. The Clearbridge Llc holds 823,399 shares with $65.82 million value, down from 860,319 last quarter. Lowes Cos Inc now has $83.69 billion valuation. The stock increased 5.35% or $5.12 during the last trading session, reaching $100.86. About 14.25 million shares traded or 127.80% up from the average. Lowe's Companies, Inc. (NYSE:LOW) has risen 5.92% since January 14, 2017 and is uptrending. It has underperformed by 10.78% the S&P500.

Analysts expect Charles River Laboratories International, Inc. (NYSE:CRL) to report $1.26 EPS on February, 13.They anticipate $0.05 EPS change or 4.13% from last quarter’s $1.21 EPS. CRL’s profit would be $59.67 million giving it 20.90 P/E if the $1.26 EPS is correct. After having $1.30 EPS previously, Charles River Laboratories International, Inc.’s analysts see -3.08% EPS growth. The stock decreased 2.52% or $2.72 during the last trading session, reaching $105.34. About 694,058 shares traded or 81.70% up from the average. Charles River Laboratories International, Inc. (NYSE:CRL) has risen 7.06% since January 14, 2017 and is uptrending. It has underperformed by 9.64% the S&P500.

Investors sentiment increased to 1.46 in Q3 2017. Its up 0.09, from 1.37 in 2017Q2. It increased, as 18 investors sold Charles River Laboratories International, Inc. shares while 92 reduced holdings. 55 funds opened positions while 106 raised stakes. 44.95 million shares or 0.15% less from 45.02 million shares in 2017Q2 were reported. Paloma Mgmt Com reported 4,100 shares stake. Columbus Circle Invsts has invested 0.04% in Charles River Laboratories International, Inc. (NYSE:CRL). Cantab Cap Partners Limited Liability Partnership owns 14,316 shares or 0.22% of their US portfolio. Ls Investment Advisors Ltd holds 0.02% or 3,809 shares in its portfolio. Bessemer Group Inc Inc has 1,760 shares. The Colorado-based Alps Advsr Incorporated has invested 0% in Charles River Laboratories International, Inc. (NYSE:CRL). Advisor Prtnrs Lc stated it has 2,151 shares or 0.05% of all its holdings. Bbva Compass Financial Bank holds 0.04% or 6,110 shares in its portfolio. 13,500 were accumulated by Gabelli Funds Ltd Limited Liability Company. Eqis Cap Management has invested 0.03% in Charles River Laboratories International, Inc. (NYSE:CRL). Moreover, Jennison Associates Ltd Llc has 0% invested in Charles River Laboratories International, Inc. (NYSE:CRL) for 17,241 shares. Credit Agricole S A has 0% invested in Charles River Laboratories International, Inc. (NYSE:CRL). Lsv Asset Mgmt accumulated 26,500 shares. 35 were reported by Winfield Associates Inc. Utah Retirement Systems holds 0.02% or 8,597 shares.

Charles River Laboratories International, Inc., an early-stage contract research company, provides drug discovery and development services worldwide. The company has market cap of $4.99 billion. It operates through three divisions: Research Models and Services , Discovery and Safety Assessment (DSA), and Manufacturing Support (Manufacturing). It has a 25.72 P/E ratio. The RMS segment produces and sells research model strains primarily genetically and microbiologically defined purpose-bred rats and mice for use by researchers.

Among 16 analysts covering Charles River Laboratories (NYSE:CRL), 8 have Buy rating, 1 Sell and 7 Hold. Therefore 50% are positive. Charles River Laboratories had 39 analyst reports since August 3, 2015 according to SRatingsIntel. The company was downgraded on Tuesday, September 6 by UBS. As per Thursday, August 31, the company rating was maintained by Robert W. Baird. The company was upgraded on Wednesday, January 4 by Evercore. Jefferies maintained Charles River Laboratories International, Inc. (NYSE:CRL) on Monday, September 11 with “Buy” rating. Wells Fargo upgraded the shares of CRL in report on Thursday, January 7 to “Outperform” rating. The stock has “Hold” rating by KeyBanc Capital Markets on Thursday, October 12. On Friday, May 20 the stock rating was maintained by Barclays Capital with “Underweight”. Jefferies maintained Charles River Laboratories International, Inc. (NYSE:CRL) on Monday, April 24 with “Buy” rating. The firm has “Buy” rating given on Monday, October 9 by Jefferies. The firm earned “Buy” rating on Friday, November 10 by Bank of America.

Since August 14, 2017, it had 0 insider purchases, and 6 selling transactions for $4.64 million activity. Shares for $382,229 were sold by FOSTER JAMES C on Tuesday, January 2. 4,000 shares valued at $399,632 were sold by Barbo William D on Thursday, August 17. Shares for $289,297 were sold by Molho Davide. $171,228 worth of Charles River Laboratories International, Inc. (NYSE:CRL) was sold by Smith David Ross. $2.72M worth of Charles River Laboratories International, Inc. (NYSE:CRL) was sold by JOHST DAVID P on Thursday, October 5.

Investors sentiment increased to 1.04 in 2017 Q3. Its up 0.01, from 1.03 in 2017Q2. It improved, as 76 investors sold LOW shares while 406 reduced holdings. 115 funds opened positions while 384 raised stakes. 589.78 million shares or 2.68% less from 606.01 million shares in 2017Q2 were reported. Oppenheimer & Com Inc stated it has 0.28% in Lowe's Companies, Inc. (NYSE:LOW). 5,844 are held by Ledyard Financial Bank. Riggs Asset Managment Inc holds 408 shares. Icm Asset Incorporated Wa holds 153,770 shares. Gideon Cap Advsrs owns 3,080 shares for 0.24% of their portfolio. Apg Asset Nv invested 0.16% in Lowe's Companies, Inc. (NYSE:LOW). Ashfield Capital Prtnrs Limited invested 0.12% in Lowe's Companies, Inc. (NYSE:LOW). Commerce Bankshares holds 0.58% in Lowe's Companies, Inc. (NYSE:LOW) or 534,822 shares. Gateway Advisers Limited Liability Com has 657,982 shares for 0.46% of their portfolio. Umb Fincl Bank N A Mo stated it has 0.03% in Lowe's Companies, Inc. (NYSE:LOW). Kentucky Retirement Systems accumulated 52,686 shares or 0.32% of the stock. Guggenheim Capital Limited Liability reported 0.13% stake. Meeder Asset Management holds 0.08% or 8,845 shares. Chatham Gp owns 61,972 shares. Gotham Asset Llc holds 0.96% or 820,267 shares.

Among 33 analysts covering Lowe’s Companies Inc. (NYSE:LOW), 19 have Buy rating, 1 Sell and 13 Hold. Therefore 58% are positive. Lowe’s Companies Inc. had 76 analyst reports since August 19, 2015 according to SRatingsIntel. The stock of Lowe's Companies, Inc. (NYSE:LOW) has “Hold” rating given on Wednesday, November 22 by SunTrust. The firm has “Buy” rating by KeyBanc Capital Markets given on Wednesday, November 22. The firm earned “Buy” rating on Monday, October 30 by RBC Capital Markets. On Thursday, November 19 the stock rating was maintained by RBC Capital Markets with “Outperform”. Atlantic Securities downgraded the shares of LOW in report on Tuesday, November 28 to “Neutral” rating. On Monday, November 27 the stock rating was upgraded by Raymond James to “Outperform”. Piper Jaffray maintained the shares of LOW in report on Wednesday, November 22 with “Hold” rating. On Thursday, July 20 the stock rating was maintained by Jefferies with “Hold”. Stifel Nicolaus reinitiated the shares of LOW in report on Tuesday, August 2 with “Buy” rating. BMO Capital Markets maintained Lowe's Companies, Inc. (NYSE:LOW) on Tuesday, July 18 with “Buy” rating.

Clearbridge Llc increased Monro Inc (NASDAQ:MNRO) stake by 26,880 shares to 320,829 valued at $17.98M in 2017Q3. It also upped Healthequity Inc (NASDAQ:HQY) stake by 44,640 shares and now owns 534,470 shares. Methode Electrs Inc (NYSE:MEI) was raised too.

Since September 19, 2017, it had 0 insider buys, and 2 sales for $778,532 activity. Hollifield Matthew V also sold $614,857 worth of Lowe's Companies, Inc. (NYSE:LOW) on Friday, September 22. The insider Ramsay Paul D sold 2,098 shares worth $163,675.

Analysts await Lowe's Companies, Inc. (NYSE:LOW) to report earnings on March, 7. They expect $0.86 EPS, 0.00% or $0.00 from last year’s $0.86 per share. LOW’s profit will be $713.60 million for 29.32 P/E if the $0.86 EPS becomes a reality. After $1.05 actual EPS reported by Lowe's Companies, Inc. for the previous quarter, Wall Street now forecasts -18.10% negative EPS growth.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>